BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12871326)

  • 1. Novel Aalpha chain truncation (fibrinogen Perth) resulting in low expression and impaired fibrinogen polymerization.
    Homer VM; Mullin JL; Brennan SO; Barr A; George PM
    J Thromb Haemost; 2003 Jun; 1(6):1245-50. PubMed ID: 12871326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial deletion of the αC-domain in the Fibrinogen Perth variant is associated with thrombosis, increased clot strength and delayed fibrinolysis.
    Westbury SK; Duval C; Philippou H; Brown R; Lee KR; Murden SL; Phillips E; Reilly-Stitt C; Whalley D; Ariëns RA; Mumford AD
    Thromb Haemost; 2013 Dec; 110(6):1135-44. PubMed ID: 24048413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A frameshift mutation in the human fibrinogen Aalpha-chain gene (Aalpha(499)Ala frameshift stop) leading to dysfibrinogen San Giovanni Rotondo.
    Margaglione M; Vecchione G; Santacroce R; D'Angelo F; Casetta B; Papa ML; Grandone E; Di Minno G
    Thromb Haemost; 2001 Dec; 86(6):1483-8. PubMed ID: 11776317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel fibrinogen truncation with deletion of Bbeta chain residues 440-461 causes hypofibrinogenaemia.
    Homer VM; Brennan SO; Ockelford P; George PM
    Thromb Haemost; 2002 Sep; 88(3):427-31. PubMed ID: 12353071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen Mahdia: A congenitally abnormal fibrinogen characterized by defective fibrin polymerization.
    Amri Y; Jouini H; Becheur M; Dabboubi R; Mahjoub B; Messaoud T; Sfar MT; Casini A; de Moerloose P; Toumi NEH
    Haemophilia; 2017 Jul; 23(4):e340-e347. PubMed ID: 28594476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biophysical characterization of fibrinogen Caracas I with an Aalpha-chain truncation at Aalpha-466 Ser: identification of the mutation and biophysical characterization of properties of clots from plasma and purified fibrinogen.
    Marchi R; Meyer M; de Bosch N; Soria J; Arocha-Piñango CL; Weisel JW
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):285-93. PubMed ID: 15166913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen Milano XII: a dysfunctional variant containing 2 amino acid substitutions, Aalpha R16C and gamma G165R.
    Bolliger-Stucki B; Lord ST; Furlan M
    Blood; 2001 Jul; 98(2):351-7. PubMed ID: 11435303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three cases of congenital dysfibrinogenemia in unrelated Chinese families: heterozygous missense mutation in fibrinogen alpha chain Argl6His.
    Luo M; Deng D; Xiang L; Cheng P; Liao L; Deng X; Yan J; Lin F
    Medicine (Baltimore); 2016 Sep; 95(39):e4864. PubMed ID: 27684817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe hypodysfibrinogenemia in compound heterozygotes of the fibrinogen AalphaIVS4 + 1G>T mutation and an AalphaGln328 truncation (fibrinogen Keokuk).
    Lefebvre P; Velasco PT; Dear A; Lounes KC; Lord ST; Brennan SO; Green D; Lorand L
    Blood; 2004 Apr; 103(7):2571-6. PubMed ID: 14615374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A C-terminal amino acid substitution in the gamma-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemia.
    Fujihara N; Haneishi A; Yamauchi K; Terasawa F; Ito T; Ishida F; Okumura N
    Thromb Haemost; 2010 Aug; 104(2):213-23. PubMed ID: 20589319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrospray ionization mass spectrometry identification of fibrinogen Banks Peninsula (gamma280Tyr-->Cys): a new variant with defective polymerization.
    Fellowes AP; Brennan SO; Ridgway HJ; Heaton DC; George PM
    Br J Haematol; 1998 Apr; 101(1):24-31. PubMed ID: 9576177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia.
    Kotlín R; Chytilová M; Suttnar J; Riedel T; Salaj P; Blatný J; Santrůcek J; Klener P; Dyr JE
    Thromb Res; 2007; 121(1):75-84. PubMed ID: 17408725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dimeric Aalpha chain composition of dysfibrinogenemic molecules with mutations at Aalpha 16.
    Meh DA; Siebenlist KR; Galanakis DK; Bergtrom G; Mosesson MW
    Thromb Res; 1995 Jun; 78(6):531-9. PubMed ID: 15714754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosis.
    Marchi R; Lundberg U; Grimbergen J; Koopman J; Torres A; de Bosch NB; Haverkate F; Arocha Piñango CL
    Thromb Haemost; 2000 Aug; 84(2):263-70. PubMed ID: 10959699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen Saint-Germain I: a case of the heterozygous Aalpha GLY 12 --> VAL fibrinogen variant.
    Mathonnet F; Peltier JY; Detruit H; de Raucourt E; Alvarez JC; Mazmanian GM; de Mazancourt P
    Blood Coagul Fibrinolysis; 2002 Mar; 13(2):149-53. PubMed ID: 11914657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen Guarenas, an abnormal fibrinogen with an Aalpha-chain truncation due to a nonsense mutation at Aalpha 467 Glu (GAA)-->stop (TAA).
    Marchi R; Carvajal Z; Meyer M; Soria J; Ruiz-Saez A; Arocha-Piñango CL; Weisel JW
    Thromb Res; 2006; 118(5):637-50. PubMed ID: 16406498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of additional carbohydrate in the coiled-coil region of fibrinogen on polymerization and clot structure and properties: characterization of the homozygous and heterozygous forms of fibrinogen Lima (Aalpha Arg141-->Ser with extra glycosylation).
    Marchi R; Arocha-Piñango CL; Nagy H; Matsuda M; Weisel JW
    J Thromb Haemost; 2004 Jun; 2(6):940-8. PubMed ID: 15140130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypodysfibrinogenemia causing mild bleeding and thrombotic complications in a compound heterozygote of AalphaIVS4+1G>T mutation and Aalpha4841delC truncation (Aalpha(Perth)).
    Jayo A; Arnold E; González-Manchón C; Green D; Lord ST
    Thromb Haemost; 2009 Apr; 101(4):770-2. PubMed ID: 19350124
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypofibrinogenemia in an individual with 2 coding (gamma82 A-->G and Bbeta235 P-->L) and 2 noncoding mutations.
    Brennan SO; Fellowes AP; Faed JM; George PM
    Blood; 2000 Mar; 95(5):1709-13. PubMed ID: 10688828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain.
    Stucki B; Zenhäusern R; Biedermann B; Baudo F; Redaelli R; Lämmle B; Furlan M
    Blood Coagul Fibrinolysis; 1999 Mar; 10(2):93-9. PubMed ID: 10192658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.